These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38928133)

  • 41. Rhinovirus respiratory tract infection in hospitalized adult patients is associated with T
    To KKW; Lu L; Fong CHY; Wu AKL; Mok KY; Yip CCY; Ke YH; Sze KH; Lau SKP; Hung IFN; Yuen KY
    J Infect; 2018 May; 76(5):465-474. PubMed ID: 29454786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eosinophils and chronic obstructive pulmonary diseases (COPD) in hospitalized COVID-19 patients.
    Fekri MS; Najminejad Z; Karami Robati F; Dalfardi B; Lashkarizadeh M; Najafzadeh MJ
    BMC Infect Dis; 2024 Jun; 24(1):553. PubMed ID: 38831292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis.
    Caproni M; Cardinali C; D'Agata A; Selvaggi W; Fabbri P
    Int Arch Allergy Immunol; 2002 May; 128(1):67-72. PubMed ID: 12037403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique.
    Jeziorska M; Haboubi N; Schofield P; Woolley DE
    J Pathol; 2001 Aug; 194(4):484-92. PubMed ID: 11523058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different cytokine and chemokine profiles in hospitalized patients with COVID-19 during the first and second outbreaks from Argentina show no association with clinical comorbidities.
    Almada L; Angiolini SC; Dho ND; Dutto J; Gazzoni Y; Manzone-Rodríguez C; Marín C; Ponce NE; Arroyo DS; Quiróz JN; Iribarren P; Cerbán FM; Morón G; Amezcua Vesely MC; Cervi L; Chiapello LS; Fozzatti L; Icely PA; Maccioni M; Montes CL; Motrán CC; Rodríguez-Galán MC; Stempin CC; Viano ME; Mena C; Bertone M; Abiega CD; Escudero D; Kahn A; Caeiro JP; Maletto BA; Acosta Rodríguez EV; Gruppi A; Sotomayor CE
    Front Immunol; 2023; 14():1111797. PubMed ID: 36817433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
    Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
    J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Granulocytic Signature Identifies COVID-19 and Its Severity.
    Vitte J; Diallo AB; Boumaza A; Lopez A; Michel M; Allardet-Servent J; Mezouar S; Sereme Y; Busnel JM; Miloud T; Malergue F; Morange PE; Halfon P; Olive D; Leone M; Mege JL
    J Infect Dis; 2020 Nov; 222(12):1985-1996. PubMed ID: 32941618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children.
    Hossny E; Aboul-Magd M; Bakr S
    Allergy; 2001 Oct; 56(10):996-1002. PubMed ID: 11576081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
    Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
    Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
    Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
    Front Immunol; 2021; 12():648004. PubMed ID: 33767713
    [No Abstract]   [Full Text] [Related]  

  • 54. Reductions in eosinophil biomarkers by benralizumab in patients with asthma.
    Pham TH; Damera G; Newbold P; Ranade K
    Respir Med; 2016 Feb; 111():21-9. PubMed ID: 26775606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eosinophil recovery in hospitalized COVID-19 patients is associated with lower rates of ICU admission and in-hospital mortality: An observational cohort analysis.
    Yan PD; Markovic D; Hixson RY; Shover CM; Buhr RG; Salehi-Rad R; LeMaster B; Tashkin DP; Fulcher JA; Barjaktarevic IZ
    Respir Med Res; 2023 Nov; 84():101031. PubMed ID: 37647739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
    Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
    Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus.
    Zheng M; Wang X; Guo H; Fan Y; Song Z; Lu Z; Wang J; Zheng C; Dong L; Ma Y; Zhu Y; Fang H; Ye S
    J Diabetes Res; 2021; 2021():9526701. PubMed ID: 33490288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
    Hammoudeh SM; Hammoudeh AM; Bhamidimarri PM; Al Safar H; Mahboub B; Künstner A; Busch H; Halwani R; Hamid Q; Rahmani M; Hamoudi R
    Front Immunol; 2021; 12():595150. PubMed ID: 34262555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
    Petrey AC; Qeadan F; Middleton EA; Pinchuk IV; Campbell RA; Beswick EJ
    J Leukoc Biol; 2021 Jan; 109(1):55-66. PubMed ID: 32930456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
    Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.